Abstract: A tracheal tube insertion aid kit (1) assists in inserting a tracheal tube (9) from an oral cavity (B) of a patient (A) into an endotracheal space (E) through a glottis (D) using an indirect glottis viewing type laryngoscope (2) not equipped with the tracheal tube (9). The tracheal tube insertion aid kit (1) includes a guide tube (11) having flexibility and formed to be insertable into the endotracheal space (E) from the oral cavity (B) through the glottis (D), and a guide wire (12) formed to be insertable through the inside of the guide tube (11) and insertable into the endotracheal space (E) from the oral cavity (B) through the glottis (D).

Abstract: The present invention provides novel medical means to facilitate glutathione (GSH) synthesis in the brain. These means are miR-96-5p inhibitor increasing GSH expression in the brain and a pharmaceutical composition comprising the miR-96-5p inhibitor and having a preventive and/or therapeutic performance to a disease caused by decrease of GSH amount or depression of GSH activity.

Abstract: Provided is a cyclodeviation measurement device capable of performing quantitative measurement at low cost and capable of being used not only for diagnosis in an examination room and but also during a surgical operation in a surgical operating room, which has not been considered so far. In addition, provided is an improved device of the above device which can perform cyclodeviation measurement at a position other than the front by stabilizing vision fixation. The cyclodeviation measurement device includes a board, a pair of Maddox rods provided on the board so that at least one Maddox rod is rotatable, a manipulation means capable of freely rotating the rotatable Maddox rod, and an indication means indicating a rotation angle of the Maddox rod. The improved device includes a pair of a Maddox rod and a Bagolini striated lens instead of a pair of the Maddox rods.

Abstract: A composition with an enhanced antifungal activity, which comprises peptides as a protamine hydrolysate and which is suitable for industrial application at a low cost, can be provided, by using a combination of a protamine hydrolysate and a terpene alcohol as an active ingredient of a composition having an antifungal activity.

Abstract: The present invention provides novel medical means to facilitate glutathione (GSH) synthesis in the brain. These means are miR-96-5p inhibitor increasing GSH expression in the brain and a pharmaceutical composition comprising the miR-96-5p inhibitor and having a preventive and/or therapeutic performance to a disease caused by decrease of GSH amount or depression of GSH activity.

Abstract: Provided is a cyclodeviation measurement device capable of performing quantitative measurement at low cost and capable of being used not only for diagnosis in an examination room and but also during a surgical operation in a surgical operating room, which has not been considered so far. In addition, provided is an improved device of the above device which can perform cyclodeviation measurement at a position other than the front by stabilizing vision fixation. The cyclodeviation measurement device includes a board, a pair of Maddox rods provided on the board so that at least one Maddox rod is rotatable, a manipulation means capable of freely rotating the rotatable Maddox rod, and an indication means indicating a rotation angle of the Maddox rod. The improved device includes a pair of a Maddox rod and a Bagolini striated lens instead of a pair of the Maddox rods.

Abstract: The present invention provides novel medical means to facilitate glutathione (GSH) synthesis in the brain. These means are miR-96-5p inhibitor increasing GSH expression in the brain and a pharmaceutical composition comprising the miR-96-5p inhibitor and having a preventive and/or therapeutic performance to a disease caused by decrease of GSH amount or depression of GSH activity.

Abstract: The object of the present invention is to provide a biomarker which is highly correlated to the conventional biomarkers of metabolic syndrome or life-style related disease in a wide range of subjects to be tested, including subjects of special health check-up aged between 40 and 74, or an advantageous method for detecting metabolic syndrome or life-style related disease. The object can be solved by a method for detecting metabolic syndrome or life-style related disease by measuring the concentration of choline plasmalogen in a sample to be tested.

Abstract: The object of the present invention is to provide a biomarker which is highly correlated to the conventional biomarkers of metabolic syndrome or life-style related disease in a wide range of subjects to be tested, including subjects of special health check-up aged between 40 and 74, or an advantageous method for detecting metabolic syndrome or life-style related disease. The object can be solved by a method for detecting metabolic syndrome or life-style related disease characterized by comprising the step of measuring the concentration of choline plasmalogen in a sample to be tested.

Abstract: The present invention provides a method for measuring a particular protein in a sample containing at least one protein, wherein the sample is reacted with a reagent cleaving a peptide bond of the particular protein to generate a soluble peptide fragment which is determined by a certain primary structure; and contacted with a reagent reacting specifically with the particular soluble peptide fragment, thereby detecting the presence of the particular soluble peptide fragment.